Overview
Updated 14 Jul 2026
Charles Rudin, MD, PHD, is Chief, Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center. The public record shows 1,717 publications with 88,670 citations (h-index 135), centered on Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 25 companies, 7 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · Cancer discovery
- Top research focus: Lung Cancer Research Studies
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 25 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 129 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 454.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 1/PHASE2RecruitingNCT06287775 - DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
InvestigatorPhase 1/PHASE2TerminatedNCT03879798 - Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer
Sponsor: ECOG-ACRIN Cancer Research Group
InvestigatorPhase 1/PHASE2CompletedNCT01824901
Industry payments
Updated 14 Jul 2026
25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20257 payments$14,135openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202510 payments$13,051openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20253 payments
NIH funding
Updated 14 Jul 2026
7 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Coordinating center for the NCI small cell lung cancer research consortium
Sloan-Kettering Inst Can Research
FY2026$1,149,864U24CA213274 - Coordinating center for the NCI small cell lung cancer research consortium
Sloan-Kettering Inst Can Research
FY2025$1,379,839U24CA213274
Congress activity
Updated 14 Jul 2026
210 congress contributions (2004–2025) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 6382: DNA damage repair pathways enable a drug-tolerant persister state in RET-fusion NSCLC and precedes TKI resistance
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.
Science translational medicine
2026
Most-cited worksby citation count (OpenAlex)
- 01
- 02
- 03
- 04
- 05Small-cell lung cancer1,541 citations2021
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
David H. Koch Center for Cancer Care, 530 East 74th Street, New York, NY 10021
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
University of Chicago Pritzker School of Medicine (Medical Scientist Training Program)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-asci.org ↗ - PhD
University of Chicago Pritzker School of Medicine (Medical Scientist Training Program)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-asci.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- Member
National Cancer Institute Board of Scientific Advisors
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗ - Principal Investigator
two Stand Up to Cancer grants at MSK
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
- Paul A. Bunn
Jr. Scientific Award (lifetime achievement in thoracic cancer research), International Association for the Study of Lung Cancer
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu ↗
- Faculty
Weill Cornell Graduate School of Medical Sciences (Pharmacology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →gradschool.weill.cornell.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.gov ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →outcomes4me.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/charles-rudin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
synapse.mskcc.org/synapse/people/13476
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →synapse.mskcc.org ↗ - Other
mskcc.org/cancer-care/doctors/charles-rudin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Mentions by otherswhere others cite or feature them
- Facebook
facebook.com/IASLC/posts/dr-charles-rudin-of-memorial-sloan-kettering-cancer-center-discusses-ongoing-imm/1692604060786666
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
mskcc.org/videos/meet-charles-rudin-thoracic-medical-oncologist-at-msk
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
- 1,588
- publications
- 150
- h-index
- 18
- trials
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
- 639
- publications
- 131
- h-index
- 4
- trials
Sergio Giralt, MD
Memorial Sloan Kettering Cancer Center
- 1,809
- publications
- 122
- h-index
- 17
- trials